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A range of proteins has been recognized as mediators/hypothetical receptors for hepatitis B virus 
(HBV), but the results are conflicting and inconclusive especially regarding their biological significance. 
This study was aimed at identifying a novel HBV-interacting protein which would provide a better 
understanding of its transport in blood, attachment, fusion and entry into hepatocytes. Serum samples 
positive for HBV confirmed by PCR were subjected to ammonium sulfate fractionations at 50, 75, 100%, 
saturation. PCR of each fraction demonstrated amplification of HBV in 100% fraction. Protein analysis 
by SDS PAGE of fractions showed one band of approximately 69 kDa protein, in 100% fraction. The 
100% fraction band was excised from gel and sequence was determined by MALDI TOF which showed 
mass values from 705 to 3722. Mass spectrometry of trypsinized 69 kDa species revealed peptide 
sequences that covered 54% of the serum albumin precursor amino acid sequence, with pI of 5.9. 
Western blot, carried out using primary anti-albumin precursor antibody, further validated this protein. 
This study establishes that Hepatitis B Virus binds to albumin precursor, suggesting its role in the 
initiation of HBV infection and hence may offer new therapeutic strategies against HBV infection. 
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INTRODUCTION  
 
The Hepatitis B Virus (HBV) was discovered nearly 40 
years back, yet the search for a receptor or a carrier 
protein is still going on. Despite considerable advances in 
the understanding of the nature of HBV disease, many of 
the steps in the virus life cycle remain unclear. Virus 
transport in blood, attachment to permissive cells, fusion 
and penetration through cell membranes and subsequent 
genome release, are largely an ambiguity. Current know-
ledge on the early steps of HBV life cycle has mostly 
evolved from molecular cloning and studies of the 
infection of duck hepatitis B virus (DHBV). However, 
considering the difference of composition and sequence 
between the surface protein of HBV and entry may be 
restricted (Lu and Block, 2004). Efforts to identify the cell  
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surface receptor(s) for HBV have been hampered by the 
limitations of the in vitro models of HBV infection and non 
availability of in vivo models. A recent study (Deng et al., 
2007), has suggested interaction (virus binding, virus 
capture, and cell attachment) of lipoprotein lipase (LPL), 
with PreS and HBV particles, but this too has been an in 
vitro study. Similarly, an array of proteins has been described 
as putative receptors for HBV; however, the biological 
significance of these molecules has not been confirmed 
(Barrera et al., 2005). This study was aimed at identifying 
a novel HBV-interacting protein which would provide a 
better understanding of its transport in blood, its attach-
ment to hepatocytes, fusion and entry into the cells. 
 
 
MATERIALS AND METHODS 
 
All work was done at molecular biology laboratory at Aga Khan 
University, Karachi, Pakistan. Serum samples collected (by 
informed consent) from patients attending clinic at Ziauddin Medical  
University  were  stored  at  minus  70ºC  until  analysed. Only  HBV 
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positive sera detected by HBsAg (ELISA-MUREX kit by Abbot 
Laboratory) were included in this study. Ethical approval for this 
study was granted by the Ziauddin University ethical review com-
mittee.  
 
 
Protein precipitation and quantification 
 
Proteins from HBV positive serum were fractionated by using vary-
ing concentrations of NH4(SO4)2 as described by Spadaro et al. 
(2003). Serum samples (200 µl each) of HBV infected high titer 
patients were subjected to ammonium sulphate precipitation and 
four fractions at 50, 75, 100 and supernatant of 100% were col-
lected. The protein yield in each fraction was quantified by Bradford 
Method. A standard curve was drawn for this purpose, using 
solutions of bovine serum albumin (BSA) as standard, according to 
the method of Gornall et al. (1949).   
 
 
DNA extraction and PCR amplification 
 
In order to detect HBV associated protein fraction, DNA extraction 
was performed on all four fractions namely, 50, 75, 100% and the 
supernatant, using a DNA extraction kit (QIA AMP DNA mini kit 250 
reactions Cat #51306). 
PCR was performed to ascertain which fraction holds the activity 
of HBV, by using primers for HBV, P7F and P7R (from Gene Link 
NY, USA), for core protein. For reference HBV Clone of 620bp 
(reference strain; AF460235) was used as an appropriate positive 
control and to monitor the efficacy of PCR protocol.  Reaction mix 
for each tube contained DNA (10 µl), 10x buffer (50 mM KCl, 10 
mM Tris pH 8.3), MgCl2 (2 mM), dNTPs (200 M), P7F and P7R (20 
pmol each), H2O (28.7 µl), Taq polymerase (2.5 U), with the Cycling 
as 94°C pre denaturation for 2 min, 94°C for 30 s,  55°C for 30 s,  
72°C for 1 min for  35 cycles, 72°C for 7 min, and 4°C hold. To the 
positive control tube instead of DNA 1.0 µl of Clone template plus 
9.0 µl of H2O was added. For visualization of PCR product 2.5% 
agarose was prepared in 1x TBE buffer. The gel was run in 1x TBE 
buffer at a voltage of 90V. The amplified bands were visualized on 
Gel Doc system Quantity One (BioRad company, USA) with a 
medium or long wavelength (e.g. 300 nm) UV light and recorded in 
a TIFF file.   
 
 
Polyacrylamide Gel Electrophoresis (PAGE) 
 
Proteins fractionated by ammonium sulphate were analyzed by 
SDS-PAGE to determine the molecular size protein species present 
in each fraction (Spadaro et al., 2003). Each precipitated fraction 
was washed with ammonium sulfate solution at the respective salt 
concentration to improve the yield. Protein samples of fractions 50, 
75 ,100% and supernatant respectively were dissolved in sample 
diluting buffer in the ratio of 1:1 by boiling in a water bath for 3 min 
and resolved on 10% SDS PAGE . Electrophoresis was performed 
using tris-glyine buffer at constant voltage of 90V/plate of 10 mm 
length and 1 mm in thickness, for approximately 1 h; or till the dye 
migrated 95% of the gel length. The gels were stained with 
Coomassie Brilliant Blue-R (CBBR) and de-stained with glacial 
acetic acid (10%) to visualize the protein components.  
The 69 kDa band (separated out on 100% fraction) was extracted 
from the SDS-PAGE gel and digested with trypsin, and the peptide 
masses were examined by mass spectrophotometry.  
 
 
MALDI TOF 
 
Mass spectrophotometry of the excised band from gel of 10% SDS 
PAGE was done as described by Hong et al. (2004). Protein bands 
were excised manually from Coomassie  Blue  stained  SDS  PAGE 
 
 
 
 
gels and in-gel digested with trypsin using a Mass PREP robotic 
protein-handling system (Micromass). The samples were loaded 
onto the ZipTip by pipetting 20 times and washed using 10 l 0.1% 
TFA twice. The tryptic fragments were eluted with 60% acetonitrile / 
1% acetic acid. The tryptic fragments were mass analyzed by 
matrix-assisted laser desorption ionization (MALDI) mass spectro-
metry (Voyager DE-PRO; Applied Biosystems) and Q-TOF Ultima 
API (Micromass) was employed for sequence information. For LC-
MS the material obtained after in-gel digestion was directly applied 
on a Q-TOF Ultima API (Micromass) instrument coupled with on-
line CapLC (Waters). A column from Genetec, PepMap C18 3 m, 
100°A, 75 m x 150 mm was employed for separation of peptides 
prior to entry into mass spectrometer. For peptides separation, 
samples were applied on the column in buffer A containing 5% 
acetonitrile in water and 0.1% formic acid, eluted with buffer B, 
containing 95% acetonitrile in water and 0.1% formic acid. The 
(M+H)+ values for the peptide fragments produced by trypsin 
digestion were used for protein identification with MS-FIT program 
on Protein Prospector. Proteins were identified from peptide mass 
data by using BLAST search at 
http://www.ncbi.nlm.nih.gov/blast/blast.cgi 
 
 
Western blotting 
 
The protein fractions were solubilized in Laemmli sample buffer 
(Laemmli, 1970) and resolved on 10% SDS PAGE. Subsequently, 
the protein fractions were blotted on to a nitrocellulose (HybondTM 
ECL, GE Healthcare Life Science) 
Nitrocellulose membrane was pre-wet with distilled water and 
then soaked in transfer buffer. The cassette was opened into a tray 
filled with transfer buffer. A foam sponge was placed on the open 
submersed cassette and pressed gently to expel any air bubble. 
Four sheets of blotting paper were placed on the sponge and the 
membrane was placed on the blotting paper. The gel was then 
placed on the membrane. All air bubbles were removed by gently 
rolling a glass pipette over the gel. The gel was then covered with 
four sheets of blotting paper and a sponge (6 mm). The cassette 
was then closed and inserted into the transfer unit containing 
transfer buffer. A cooling system was connected to the heat 
exchanger outlet of the tank and water was circulated at 10°C. A 
magnetic stirrer was placed in the buffer tank. Transfer was allowed 
at 250 mA for 4 h.  
 
 
Incubation of the nitrocellulose membrane with antibody 
 
The albumin precursor protein was detected with primary mono-
clonal antibody (Sigma-Aldrich, Saint Louis Missouri, USA), that is, 
anti-albumin precursor antibody (1:500) in conjugation with the 
horse radish peroxidase conjugated secondary antibody (1:10,000) 
and visualized using ECL detection kit (GE Healthcare) according 
to the manufacturers’ instructions. 
 
 
RESULTS 
 
Amplification of HBV in 100% fraction 
 
A band of 140 bp length (nucleotide 2298 to 2436) of the 
C gene of HBV DNA was found more prominent in the 
PCR of 100% fraction signifying HBV activity along with 
the protein precipitated on 100% saturation (Figure 1). 
The first two fractions (50 and 75%) did not show any 
noticeable amplification. The positive control HBV clone 
used as the template amplified a 140 bp  fragment  insert 
  
 
 
  1         2              3                4            5   6 
 
 
Figure 1.  PCR amplification to determine the HBV activity. 
Lane 1, DNA  100 bp ladder, lane 2, supernant of 100% 
ammonium sulfate fraction, lane 3, amplified product of 140bp 
was observed in 100% ammonium sulfate precipitated 
fraction, lane 4, ammonium sulfate 75% fraction, lane 5, 
ammonium sulfate 50% fraction and lane 6,  HBV Clone was 
used as positive control. 
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Figure 2. Proteins fractionated by ammonium 
sulphate were analyzed by SDS-PAGE. Lane 1, 
shows SDS-PAGE low molecular weight standard, 
lane 2, ammonium sulfate 50% fraction, lane 3, 
ammonium sulfate 75% fraction and lane 4,  
ammonium sulfate 100% fraction. 
 
 
 
The normal controls (HBsAg negative patients) did not 
give any results on PCR amplification (results not 
shown). 
 
 
A single band of 69 kDa in 100% fraction on SDS  
 
The first two fractions, namely 50 and 75% salt concen-
trations, revealed presence of two major groups of pro-
teins; globulins and albumins respectively, as analyzed 
by SDS page. The third fraction (100%) presented a 
single band at 69 kDa position and the fourth  fraction  re-  
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revealed no band (Figure 2). Thus PCR negative frac-
tions establish that globulins and albumins do not carry 
HBV and it is the third fraction that grasped all the 
attention. 
 
 
Mass Spectrophotometry identifies 69 kDa as 
albumin precursor   
                                                                                 
The peptide sequences of 69 kDa band, excised from the 
lane of 100% fraction on SDS-PAGE gel and digested 
with trypsin, were examined by mass spectrometry. The 
results, based on MALDI-TOF MS showed mass values 
from 705 to 3722 (Figure 3). Analysis of these masses 
through Protein Prospector revealed peptide sequences 
that covered 54% of the Serum Albumin Precursor amino 
acid sequence, with molecular weight of 69 kDa, pI of 
5.9/. 
 
 
Western blotting confirms albumin precursor 
 
Analysis shows a high expression of albumin precursor 
protein at position which coincides with the 69 kDa band 
of 3rd fraction (100%) on SDS PAGE, showing a protein-
primary antibody-secondary antibody-enzyme complex, 
proving the  presence of albumin precursor (Figure 4). 
 
 
DISCUSSION 
 
This study identifies albumin precursor as HBV binding 
protein which may be involved in interaction with the 
membrane receptor mediating the attachment to the liver 
cells. The data presented demonstrate the presence of 
HBV only in the fraction which was later identified to con-
tain albumin precursor. It appears that albumin precursor 
of 69 kDa protein is similar to albumin yet has different 
characteristics in terms of molecular weight and no cross 
reactivity with antibody to albumin.  
Since the discovery of HBV despite intensive efforts, a 
clear understanding about receptor or binding protein for 
HBV remains elusive. It is known that HBV, for its entry 
into the hepatocyte requires a binding protein and a cel-
lular receptor (Lonberg and Philipson, 1981). Once it 
passes the attachment and entry steps of infection, HBV 
is able to replicate freely in hepatic cells. Many proteins 
have been identified as HBV envelope binding proteins 
with a proposed role as mediators in HBV attachment to 
the hepatocyte. At the same time, many theories have 
been proposed regarding HBV attachment and entry into 
hepatocytes but none of these theories or binding pro-
teins have been thoroughly proved or investigated.  
In this study, the albumin precursor precipitated along 
with the third fraction (100% ammonium sulfate satura-
tion) of serum as was proved by analysis of this fraction 
by mass spectrometry and western blotting. It is impor-
tant to note that this was the only fraction that turn out to 
be  PCR   positive   for   HBV,   while  all  other  fractions 
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Figure 3. MALDI-TOF MS of 69 kDa protein obtained from one piece of silver-stained SDS- PAGE gel. 
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Figure 4. Western blot analysis of albumin precursor 
protein after ammonium sulfate fractionations of serum 
samples. Samples were HBV positive serum was 
fractionated; lane 1, with 50%, lane 2, 75% and lane 3, 
100% ammonium sulfate. 
 
 
 
mained negative. This also suggests that a strong affinity 
exists between HBV and the precipitated protein in this 
fraction. The protein band of 100% fraction on SDS 
PAGE was not as intense as the band on western blott-
ing. One reason for this difference could be the binding 
affinity of CBBR, the coomassie blue stain  used for SDS 
gel staining, bind to proteins via physisorption to arginine, 
the aromatic amino acids, and histidine. Albumin, out of 
its 650 amino acids is comparatively low in these amino 
acids. Secondly, CBBR binds poorly to less soluble pro-
teins in acidic medium. 
Early research  has  shown  association  between  HBV 
 
and albumin, but not with albumin precursor as revealed 
in this study. It is well established that human albumin is 
initially synthesized as a proprotein and subsequently 
transformed into serum albumin (Weigand and Alpert, 
1981). The proalbumin, differs from circulating serum 
albumin only in containing a basic hexapeptide, Arg-Gly-
Val-Phe-Arg-Arg, at its NH2 terminus (Peters, 1996). 
Repeatedly conflicting views have been published 
describing cooperation of so-called polymerized albumin 
with HBV. It has been demonstrated that pHSA binds to 
HBsAg particles (Pontisso et al., 1983) within the pre-S2 
amino acid sequence (Machida et al., 1984).  In 1989, 
Pontisso and his colleagues, using the membranes of 
surgically obtained human liver as a target, described the 
role of HBV preS2 region as a specific site that binds the 
poly-human albumin in vitro. They showed that pHSA is 
necessary and sufficient for the attachment of pre-S2-
containing M-rHBsAg particles to human liver plasma 
membranes. They also showed that pHSA enhances the 
L-rHBsAg particle binding to these membranes. Other 
investigators also reported similar findings with poly-
human albumin in vitro (Machida et al., 1983) and the 
monomeric human albumin in vivo (Krone et al., 1990; Lu 
et al., 1988), but it  was  neither  investigated  further  nor  
  
 
 
confirmed. Other reports have demonstrated that native 
and glutaraldehyde-polymerized albumins bind to hepato-
cytes (Lenkei et al., 1977; Trevisan et al., 1982; Wright et 
al., 1987; Yu et al., 1987); however, presence of pHSA in 
vivo has not been established. It is therefore, not clear 
whether pHSA plays a   role in HBV infection or not.   
Preceding research did not report expression of 
albumin precursor as binding protein of Hepatitis B Virus. 
However, a number of proteins have been recognized as 
HBV envelope binding proteins with a proposed role as 
mediators in HBV attachment to the hepatocytes. These 
proteins have been identified to interact with various HBV 
domains. Thus, apolipoprotein H, (Mehdi et al., 1994) that 
binds to S domain; human serum albumin and a human 
soluble serum factor (Budkowska et al., 1993) and a 44 
kDa protein (Falco et al., 2001) are to name a few in this 
regard. Neurath and his colleagues in 1994 discovered 
the binding site on pre-Sl domain from amino acid 
sequence 21 to 47 which is involved in the recognition of 
hepatocyte receptors. Recently, Blanchet and Sureau 
(2007) by mapping the entire pre-S domain for infectivity 
determinants demonstrated that the activity of the pre-S 
domain at viral entry solely depends on the integrity of 
only its first 75 amino acids. While De Falco et al. (2001) 
identified a 44 kDa protein by using the pre-S1 peptide 
originally shown to bind liver cells by Neurath et al. 
(1994). None of the candidate proteins have demonst-
rated biological activity in HBV infectivity. Secondly, the L 
protein is modified at the amino-terminal glycine of the 
pre-S1 domain with a myristate (Persing, 1987), which is 
required for infectivity (Bruss, 1996) and none of the 
above described proteins to date have been identified 
with a pre-S1 protein containing the amino-terminal myri-
state known to be essential for infectivity. These results 
are conflicting, and no conclusive and convincing biolo-
gical data has been obtained to fully demonstrate the 
functional role of these proteins in HBV binding and inter-
nalization. Thus, the viral structures involved in attach-
ment to the target cell were identified, but the binding 
protein for HBV could not be positively deter-mined and 
the biochemical events leading to infection remain un-
known.  
The binding of HBV with albumin precursor apparently 
shows an evidence of a cargo role for albumin precursor 
in the delivery of Hepatitis B virus to the hepatic cells. 
The cargo chaperone function of albumin is to facilitate 
the delivery across the vessel wall barrier. However, it is 
not clear whether it only transports hydrophobic cargo 
molecules to specific binding proteins on the endothelial 
cell surface or it serves as an all purpose transporter 
(Peters, 1995). As far as microorganisms are concerned 
Albumin has been long realized as their ligand especially for 
bacteria. Certain Gram-positive bacteria bind tightly to 
albumins and IgG of various species has been recognized 
since 1979. The albumin provides transport and possibly 
nutrients to the invaders and increases their virulence 
(Peters, 1995).  
So far  there  is  no  documented  evidence  that  could 
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show the involvement of HBV with albumin precursor. 
Binding of HBV may be achieved through myristate to 
albumin precursor, which binds to receptor on the heap-
tocytes. Myristate has been found to have multiple (five) 
binding site on Albumin molecule (Curry et al., 1998). The 
very amino-terminal end of the pre-S1 domain, including 
the myristate group attached to it, is a putative primary 
receptor-binding domain (Blanchet and Sureau, 2006). 
Basically, two sites on its small HbsAg protein have been 
proposed by Cooper et al. (2003). One site is to attach to 
the binding protein we propose albumin precursor and a 
secondary attachment site that recognizes a distinct 
receptor on the cell membrane, supporting the hypothesis 
of a multivalent and cooperative mechanism of virus 
attachment to the cell surface, as occurs for many other 
viruses. Another factor that facilitates HBV binding to 
proteins is the presence of QLDPAF sequence within pre 
S 1 region, which has been found in all HBV samples we 
studied.  
Paran and his colleagues (2001) found that the 
QLDPAF sequence within this preS1 region was crucial 
for cell attachment. Further evidence to support this 
hypothesis is that analysis of the database revealed that 
this minimal epitope is shared by other viral, bacterial and 
cellular proteins that participate in cell adhesion, 
attachment and fusion. This suggests that the QLDPAF 
sequence or part of it may play a role in cell adherence 
and attachment.  
 
 
Conclusion 
 
Although many technical details remain to be explored, 
yet on the basis of evidence presented in this study eluci-
dates that HBV binds to albumin precursor and it would 
not be unreasonable to propose that pre S region of HBV 
might be the most likely domain involved. At this point it is 
not clear yet how Human Albumin Precursor fulfills all of 
these different functions, however, assuming that this pro-
tein acts as a chaperone, thereby stabilizing HBV struc-
tures, a function in these varied processes might be envi-
saged. 
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